Compare MTH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTH | LNTH |
|---|---|---|
| Founded | 1985 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 6.6B |
| IPO Year | 1997 | 2014 |
| Metric | MTH | LNTH |
|---|---|---|
| Price | $64.99 | $99.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $77.63 | ★ $87.00 |
| AVG Volume (30 Days) | 703.7K | ★ 901.1K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.18 | ★ 2.91 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.81 | $14.19 |
| P/E Ratio | ★ $29.59 | $34.27 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $58.03 | $49.67 |
| 52 Week High | $85.38 | $111.86 |
| Indicator | MTH | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 40.35 |
| Support Level | $63.65 | $98.81 |
| Resistance Level | $71.07 | $101.24 |
| Average True Range (ATR) | 1.87 | 0.45 |
| MACD | 0.25 | -0.03 |
| Stochastic Oscillator | 68.95 | 12.13 |
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.